当前位置:首页 - 行情中心 - 科兴制药(688136) - 财务分析 - 现金流量表

科兴制药

(688136)

  

流通市值:85.09亿  总市值:85.09亿
流通股本:2.01亿   总股本:2.01亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金594,413,026.63304,402,163.861,146,887,816.23864,229,786.56
  收到的税费返还133,574.5499,647.31498,482.6521,652.94
  收到其他与经营活动有关的现金11,972,199.156,118,879.5752,289,583.6931,040,785.68
  经营活动现金流入小计606,518,800.32310,620,690.741,199,675,882.57895,292,225.18
  购买商品、接受劳务支付的现金158,054,812.7268,088,184.9189,659,020.82138,844,276.92
  支付给职工以及为职工支付的现金115,678,074.7652,258,457.22223,605,975.34172,341,672.82
  支付的各项税费29,398,545.5320,088,985.7661,005,781.6950,118,861.02
  支付其他与经营活动有关的现金273,589,284.58144,739,915.22618,735,368.31480,718,199.88
  经营活动现金流出小计576,720,717.59285,175,543.11,093,006,146.16842,023,010.64
  经营活动产生的现金流量净额29,798,082.7325,445,147.64106,669,736.4153,269,214.54
二、投资活动产生的现金流量:
  收回投资收到的现金801,850,000344,850,0001,947,494,135.361,483,000,000
  取得投资收益收到的现金8,537,534.554,032,679.489,895,037.615,857,251.85
  处置固定资产、无形资产和其他长期资产收回的现金净额952,97030,00038,12531,225
  处置子公司及其他营业单位收到的现金净额13,499,888.74---
  收到的其他与投资活动有关的现金170,00015,0001,891,2001,756,200
  投资活动现金流入小计825,010,393.29348,927,679.481,959,318,497.971,490,644,676.85
  购建固定资产、无形资产和其他长期资产支付的现金29,948,715.588,281,017.9393,991,409.6467,241,901.91
  投资支付的现金995,850,000450,850,0001,955,862,3801,645,000,000
  支付其他与投资活动有关的现金577,000133,00013,590,05013,320,050
  投资活动现金流出小计1,026,375,715.58459,264,017.932,063,443,839.641,725,561,951.91
  投资活动产生的现金流量净额-201,365,322.29-110,336,338.45-104,125,341.67-234,917,275.06
三、筹资活动产生的现金流量:
  吸收投资收到的现金19,250,800-6,964,520-
  取得借款收到的现金420,679,579.9176,879,579.9627,655,263.9436,755,263.9
  收到其他与筹资活动有关的现金118,847.04---
  筹资活动现金流入小计440,049,226.94176,879,579.9634,619,783.9436,755,263.9
  偿还债务支付的现金287,615,207.89143,597,465.44559,465,826.85437,332,505.83
  分配股利、利润或偿付利息支付的现金36,442,873.6710,289,110.1443,634,014.8833,494,795.65
  支付其他与筹资活动有关的现金52,175,523.772,328,679.9142,434,149.3640,412,983.79
  筹资活动现金流出小计376,233,605.33156,215,255.49645,533,991.09511,240,285.27
  筹资活动产生的现金流量净额63,815,621.6120,664,324.41-10,914,207.19-74,485,021.37
四、汇率变动对现金及现金等价物的影响1,033,973.31449,313.931,391,169.29731,760.74
五、现金及现金等价物净增加额-106,717,644.64-63,777,552.47-6,978,643.16-255,401,321.15
  加:期初现金及现金等价物余额552,951,942.59553,198,403.29559,930,585.75559,930,585.75
  期末现金及现金等价物余额446,234,297.95489,420,850.82552,951,942.59304,529,264.6
补充资料:
  净利润78,962,472.06-27,048,555.4-
  资产减值准备978,079.61-3,669,050.48-
  固定资产和投资性房地产折旧34,413,663.76-67,067,060.21-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧34,413,663.76-67,067,060.21-
  无形资产摊销13,145,669.75-20,806,116.93-
  长期待摊费用摊销3,024,930.59-5,897,822.15-
  处置固定资产、无形资产和其他长期资产的损失114,723.4--77,059.28-
  固定资产报废损失113,238.67-172,386.94-
  公允价值变动损失-15,439,757.31-29,188,617.47-
  财务费用20,135,472.81-43,357,485.96-
  投资损失-23,535,525.66--9,538,871.79-
  递延所得税2,270,936.03-12,877,959.59-
  其中:递延所得税资产减少953,775.1-16,758,057.1-
    递延所得税负债增加1,317,160.93--3,880,097.51-
  存货的减少11,930,587.07-45,886,448.54-
  经营性应收项目的减少-95,968,022.08--228,070,473.68-
  经营性应付项目的增加-13,694,468.57-69,458,817.36-
  其他6,658,137-4,366,892.5-
  现金的期末余额446,234,297.95-552,951,942.59-
  减:现金的期初余额552,951,942.59-559,930,585.75-
  现金及现金等价物的净增加额-106,717,644.64--6,978,643.16-
公告日期2025-08-232025-04-282025-04-112024-10-26
审计意见(境内)标准无保留意见
TOP↑